Keel Infrastructure Corp. Common Stock vs Liquidia Corporation Common Stock — how do they compare? Keel Infrastructure Corp. Common Stock trades at $2.41 (market cap $1.58B), while Liquidia Corporation Common Stock trades at $34 (market cap $3.04B). The key difference: Liquidia Corporation Common Stock is the larger of the two by market cap, and Keel Infrastructure Corp. Common Stock is more actively traded (40,501,716 versus 21,111,778). Which is the better fit depends on your goals — on Pluang, investors hold Keel Infrastructure Corp. Common Stock for 3 Days and Liquidia Corporation Common Stock for 0 Days on average.
| KEEL | LQDA | |
|---|---|---|
Market Cap | $1.58B | $3.04B |
Volume | 40,501,716 | 21,111,778 |
Sector | Technology | Health |
52-Week High | $6.66 | $91.03 |
52-Week Low | $1.71 | $22.02 |
Typical Hold Time | 3 Days | 0 Days |
Enterprise Value | $1.90B | $2.94B |
Signals from Pluang's Aura AI — not financial advice
KEEL trades at $2.87, down 2.71% on the day, reflecting a bearish technical trend amid weak financial performance. The company reported a net loss of $208.51M on $229.28M revenue in 2025, with negative profit margins and cash flow from operations. Despite this, analyst consensus is unanimously bullish with a $6.25 price target, citing progress in its HPC and AI data center strategy, including a recent partnership with PowerSecure for its Moses Lake campus.
The outlook hinges on successful execution of its data center pivot, offering significant upside if leasing targets are met, but high execution risk and persistent losses pose substantial threats to shareholder value. Liquidity remains supported by financing activities, yet profitability challenges and competitive pressures require careful monitoring.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Keel Infrastructure develops and owns digital and energy infrastructure for high-performance computing workloads. Its assets include data centers and power infrastructure that support AI computing.
Read more on KEEL →Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →